Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
10:00-10:20 | 10:00-10:20 |
Acute HBV related liver failure |
Raymond T. CHUNG | Massachusetts General Hospital, Boston |
10:20-10:40 | 10:20-10:40 |
Role of nutrition in critical care |
Diana A. Payawal | Fatima University Medical Center, Manila |
10:40-11:00 | 10:40-11:00 |
Diagnosis and treatment of end-stage liver disease combined with severe infection |
Tao CHEN | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
11:00-11:20 | 11:00-11:20 |
Management of ACLF in the context of liver transplantation |
Didier SAMUEL | Hospital Paul Brousse, APHP, Centre Hepato Biliaire |
11:20-11:30 | 11:20-11:30 |
Panel Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
13:45-14:05 | 13:45-14:05 |
Algorithms for managing MDR infections in liver ICU |
Rakhi Maiwall | Institute Of Liver And Biliary Sciences |
14:05-14:25 | 14:05-14:25 |
Mesenchymal stem cells therapies for Covid-19: from bench to bedside |
Bingliang LIN | The Third Affiliated Hospital of Sun Yat-sen University |
14:25-14:45 | 14:25-14:45 |
Progress in diagnosis and treatment of sepsis-related cholestatic liver disease |
Ke MA | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
14:45-15:05 | 14:45-15:05 |
ACLF and organ support |
Yu CHEN | Beijing Youan Hospital, Capital Medical University |
15:05-15:15 | 15:05-15:15 |
Panel Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
17:00-17:20 | 17:00-17:20 |
HCC: Who to transplant? |
Saeed S. HAMID | Aga Khan University,Karachi |
17:20-17:40 | 17:20-17:40 |
Biliary complications due to living donor liver transplantation |
A. Kadir DOKMECI | Liver Transplantation Center, Ankara University |
17:40-18:00 | 17:40-18:00 |
HCC risk and surveillance in patients with cirrhosis |
Mindie H. NGUYEN | Stanford University Medical Center |
18:00-18:20 | 18:00-18:20 |
Prevention of HBV-related HCC through antiviral treatment |
Jinlin HOU | Nanfang Hospital, Southern Medical University |
18:20-18:30 | 18:20-18:30 |
Panel Discussion |